Data · collection · 2026
Pyrrospirone Z and related decahydrofluorene alkaloids produced by the new coprophilous species Schizothecium keniense (Schizotheciaceae, Sordariales)
Listed in GBIF
Description
This dataset contains the digitized treatments in Plazi based on the original journal article Agudelo-Restrepo, Manuela, Dibouloul, Patrick, Harms, Karen, Tchamgoue, Joseph, Stadler, Marc, Matasyoh, Josphat, Kouam, Simeon Fogue, Marin-Felix, Yasmina (2026): Pyrrospirone Z and related decahydrofluorene alkaloids produced by the new coprophilous species Schizothecium keniense (Schizotheciaceae, Sordariales). MycoKeys 136: 139-159, DOI: 10.3897/mycokeys.136.191424
Abstract
Read the rest (3 more)
A decahydrofluorene-class alkaloid, pyrrospirone Z (1 a), along with pyrrospirone F (2), pyrrospirone M (3), GKK 1032 A 2 (4), daldinol (5), orthosporin (6), and 3, 4 - dihydro- 3, 4, 8 - trihydroxy- 1 (2 H) - naphthalenone (7), was purified from the new coprophilous species Schizothecium keniense, isolated from dung in Kenya. Structural elucidation was achieved using comprehensive 1 D and 2 D NMR spectroscopy, and high-resolution electrospray ionization mass spectrometry (HR-ESI-MS), with relative configurations assigned based on NOESY correlations.
Among the compounds, pyrrospirone F (2) and GKK 1032 A 2 (4) displayed significant antibacterial activity against the Gram-positive bacteria Bacillus subtilis (MIC = 4.2 μg / mL and 8.3 μg / mL, respectively) and Staphylococcus aureus (MIC = 8.3 μg / mL for both). Additionally, compounds 2 and 4 showed mild antifungal activity against the filamentous fungi Mucor hiemalis at 33.3 μg / mL. Cytotoxicity assays revealed that GKK 1032 A 2 (4) was the most potent compound, with IC 50 values ranging from 2.0 µM to 8.1 µM across the tested human cancer cell lines.
This work represents the first investigation of the chemical constituents of the genus Schizothecium and underscores the potential of coprophilous fungi as valuable sources of biologically active metabolites.
Links
Get the data
Where it is published
- GBIF dataset page gbif.org/dataset/176e595e-9f5c-40a2-99e0-4c61cfc96c34 ↗
landing page · from gbif
- DOI doi.org/10.15468/wta4n5 ↗
DOI / persistent id · from gbif
Documentation and papers
- Publisher page tb.plazi.org/GgServer/summary/72C845990EC35E70B631747787C066D7 ↗
documentation · from gbif
Catalogue records · 1
- GBIF API api.gbif.org/v1/dataset/176e595e-9f5c-40a2-99e0-4c61cfc96c34 ↗
metadata API · from gbif
Topics
- From keywords
- Life Sciences
- Inferred from text
- Cancer 75% · Mass spectrometry 75%
Provenance · 1 source records, 10 field assertions
| Source | Key | Last seen | Raw |
|---|---|---|---|
| GBIF | 176e595e-9f5c-40a2-99e0-4c61cfc96c34 | 12 d ago | JSON v1 |
| Field | Assertion | Extractor | Evidence |
|---|---|---|---|
| access_level | source · gbif | connector:gbif@1.0.0 | |
| concepts[disease].local:disease:cancer | enrichment · gbif | keyword-concept-rules@1.0.0 | title+description (75%) |
| concepts[field].local:field:life-sciences | mapping · gbif | connector:gbif@1.0.0 | |
| concepts[modality].local:modality:mass-spectrometry | enrichment · gbif | keyword-concept-rules@1.0.0 | title+description (75%) |
| created_date | source · gbif | connector:gbif@1.0.0 | |
| description | source · gbif | connector:gbif@1.0.0 | /description |
| license | source · gbif | connector:gbif@1.0.0 | |
| publication_date | source · gbif | connector:gbif@1.0.0 | |
| title | source · gbif | connector:gbif@1.0.0 | /title |
| updated_date | source · gbif | connector:gbif@1.0.0 |